
    
      A randomized, double blind placebo controlled clinical trial was carried out in 21 adult
      patients with type 2 diabetes. Acetylsalicylic acid 300mg/d was administered orally for 3
      months to study group (n=11) and placebo to the control group (n=10).
    
  